JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alter, W. A.
Right arrow Articles by Spurgeon, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alter, W. A., III
Right arrow Articles by Spurgeon, H. A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 187, Issue 1, 99-104, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECTS OF 6-HYDROXYDOPAMINE ON VAGAL CARDIOACCELERATOR SYSTEMS

William A. Alter III 1, Gerald K. Weiss 1, Donald V. Priola 1, and Harold A. Spurgeon 1

1 Department of Physiology, School of Medicine, University of New Mexico Albuquerque, New Mexico

This study was undertaken to examine the presensce of vagal cardioaccelerator systems in the dog after chemical sympathectomy. Five dogs were pretreated with 50 mg/kg of 6-hydroxydopamine (6-OHDA). Untreated dogs served as controls. Electrical stimulation of the peripheral end of the right vagosympathetic trunk elicited a marked bradycardia in both groups of dogs. After cessation of stimulation, a postvagal tachycardia was observed. There was no significant difference between the magnitude of postvagal tachycardia in the untreated and 6-OHDA-treated dogs. Cardioacceleration was also elicitd by stimulation of the vagosympathetic trunk in atropine-treated dogs and the response was designated as a vagally induced tachycardia (VIT). The magnitude of the VIT from both control and 6-OHDA-treated dogs was not significantly different. Bretylium (5.0 mg/kg) abolished the short latency, fast rate of rise characteristies of the VIT ("fast" component) in the untreated dogs and unmasked a long lateney, slow rate of rise response of the VIT ("slow" component) similar to that observed in the 6-OHDA-treated dogs. Bretylium had no effect on the VIT in the 6-OHDA-treated dogs. It was concluded that the fast component of VIT was due to cardiac sympathetic fibers present in the cervical vagosympathetic trunk. The existence of a slow component of VIT in 6-OHDA-treated dogs is consistent with the hypothesis that vagal fibers activate the release of catecholamines from intracardiac chromaffin tissue.

Submitted on December 18, 1972
Accepted on June 11, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.